Dynavax Technologies Revenue

Biotechnology Research • Emeryville, California, United States • 201-500 Employees

Dynavax Technologies revenue & valuation

Annual revenue	$316,300,000
Revenue per employee	$939,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,012,100,000
Total funding	$425,000,000

Key Contact at Dynavax Technologies

Ryan Spencer

Chief Executive Officer

Mobile @dynavax.com

Company overview

Headquarters	2100 Powell St, Suite 900, Emeryville, CA 94608, US
Phone number	+1200000098
Website	dynavax.com
NAICS	541714
SIC	283
Keywords	Infectious Diseases, Biodefense, Vaccine Manufacturing And Vaccines
Employees	201-500
Socials

Dynavax Technologies Email Formats

Dynavax Technologies uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@dynavax.com), used 63.2% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@dynavax.com	63.2%
{first initial}{last name}	jdoe@dynavax.com	36.3%

About Dynavax Technologies

Dynavax is a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines to help protect the world against infectious diseases. The Company has two commercial products, HEPLISAV-B® vaccine [Hepatitis B Vaccine (Recombinant), Adjuvanted], which is approved in the U.S., the European Union and the United Kingdom for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older, and CpG 1018® adjuvant, currently used in HEPLISAV-B and multiple adjuvanted COVID-19 vaccines. For more information about our marketed products and development pipeline, visit www.dynavax.com and follow Dynavax on LinkedIn. Dynavax is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital and veteran status.

Employees by Management Level

Total employees: 201-500

Seniority

Employees

Director

Entry

Manager

Employees by Department

Dynavax Technologies has 172 employees across 11 departments.

Departments

Number of employees

Funding Data

Explore Dynavax Technologies's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-06-11	16	$200,000,000
2025-04-06	16	$225,000,000

Funding Insights

$425,000,000

Total funding amount

$225,000,000

Most recent funding amount

Number of funding rounds

Dynavax Technologies Tech Stack

Discover the technologies and tools that power Dynavax Technologies's digital infrastructure, from frameworks to analytics platforms.

Apache HTTP Server

Web servers

Salesforce

CRM

Amazon Web Services

PaaS

Salesforce Marketing Cloud Account Engagement

Marketing automation

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

Linkedin Ads

Advertising

Apple iCloud Mail

Webmail

HSTS

Security

Open Graph

Miscellaneous

Google Analytics

Analytics

OneTrust

Cookie compliance

Frequently asked questions

Dynavax Technologies is located in Emeryville, California, US.

You can reach Dynavax Technologies at +1200000098.

Dynavax Technologies generates an estimated annual revenue of $316,267,000. This revenue figure reflects the company's market position and business performance in its industry.

Dynavax Technologies has an estimated valuation of $1,012,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Dynavax Technologies has approximately 201-500 employees. The company continues to grow its workforce to support its business operations and expansion.

Dynavax Technologies has raised a total of $425,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Dynavax Technologies

Ryan Spencer

Chief Executive Officer

Mobile @dynavax.com

4.8

40,000 users